The use of virtual visits for obesity pharmacotherapy in patients with overweight or obesity compared with in-person encounters.

ABSTRACT:

Objective

This study aimed to demonstrate noninferiority using telehealth in treating obesity with phentermine in patients with BMI ≥ 27 kg/m² with comorbidities or BMI ≥ 30 compared with the standard in-person approach over a 90-day period.

Methods

A 12-week, randomized, prospective, single-center, open label trial compared the use of virtual visits versus in-person visits for the treatment of obesity using phentermine. The primary end point was percentage mean change in body weight from baseline to 12 weeks. A noninferiority approach assuming a 3% noninferiority region was used to assess effect size differences.

Results

The weight loss in the virtual visit arm was noninferior to the in-person arm at all time points. At 12 weeks, the mean change in weight

SUBMITTER: Griebeler ML 

PROVIDER: S-EPMC9826334 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature